Table 1.
Bivariate analysis according to the exposure BMI.
| Variable | BMI ≤ 30 (n = 179) |
BMI > 30 (n = 46) |
p |
|---|---|---|---|
| Age | 75 (66–82) | 74 (66–81) | 0.712 |
| AACCI | 3 (2–5) | 4 (4–5) | 0.016 |
| AACCI ≥ 4 | 107 (59.8) | 35 (76.1) | 0.041 |
| Frail (mFI-5 ≥ 2) | 34 (19.0) | 18 (39.1) | 0.004 |
| Lateralized dominant lesion | 35 (19.6) | 12 (26.1) | 0.331 |
| Bilateral lymphadenectomy * | 129/172 (75.0) | 25/25 (100) | 0.005 |
| Reconstructive surgery | 8 (4.5) | 9 (19.6) | <0.001 |
| Diameter of dominant lesion (mm) | 27 (18–35) | 35 (21–40) | 0.029 |
| Positive lymph node * | 53/172 (30.8) | 7/25 (28.0) | 0.775 |
| Stage III–IV | 45 (25.1) | 20 (43.5) | 0.014 |
| Outcome | |||
| Clavien–Dindo 2+ | 35 (19.6) | 20 (43.5) | <0.001 |
| Vulvar complications | 15 (8.4) | 14 (30.4) | <0.001 |
| Positive margins | 27 (15.1) | 11 (23.9) | 0.154 |
| Inguinofemoral complications * | 15/172 (8.7) | 5/25 (20.0) | 0.081 |
| Number of lymph nodes * | 14 (10–18) | 14 (13–17) | 0.386 |
* Among the 172 patients in whom lymphadenectomy was performed.